06/08/2026
Every healthcare professional’s journey began with a mentor.
At UBC, nearly 13,000 clinical faculty across the province are carrying that tradition forward – mentoring the next generation while transforming health for patients and communities.
Meet six UBC clinical faculty members and discover their stories: https://bit.ly/3QhAQQB
06/04/2026
How is UBC training the next generation of healthcare providers?
In hospitals and clinics across the province where nearly 13,000 UBC clinical faculty members are delivering care while teaching and mentoring thousands of learners.
See their impact come to life in the latest issue of Pathways: https://bit.ly/3QhAQQB
06/04/2026
June is Pride Month. Explore the many Pride activities at our Vancouver and Okanagan campuses and connect with the community: https://bit.ly/3Hkn1vX
06/04/2026
UBC’s Jeff Boniface joined an international mpox response team in Sierra Leone.
The experience revealed the power of team-based care during global health emergencies and sparked new ideas to strengthen care back home.
Read more: https://bit.ly/4x2GtTf
06/02/2026
A groundbreaking AI model can help identify breast cancer patients who may face a double-threat of cancer and cardiovascular disease.
“This research marks a significant step forward in how we assess cardiovascular risk in breast cancer patients,” says study co-lead Dr. Rasika Rajapakshe. “By combining routinely collected CT imaging with clinical health records, we can detect risk earlier and more accurately than ever before—without adding extra burden to patients or the health-care system.”
Learn more: https://bit.ly/4fWLrL7
05/28/2026
Last week, hundreds of graduates from the UBC Faculty of Medicine crossed the stage and officially joined the Class of 2026. 🎓
As they begin the next chapter of their careers, this year’s grads reflect on the moments that shaped their time at UBC — both inside and outside the classroom.
From nature walks and celebrations with classmates to backcountry ski touring and representing Canada in an international soccer tournament, their journeys were filled with unforgettable experiences and milestones.
Meet the grads, discover their favourite memories and see what’s next for the Class of 2026: https://bit.ly/4fw5rnH
05/28/2026
We are delighted to welcome Dr. Jan Lünemann as the inaugural UBC Chair in Multiple Sclerosis (MS) and Autoimmune Neurology Research.
Dr. Lünemann is a world-renowned clinician-scientist whose work bridges immunology, neuroscience and clinical care to develop new therapeutics for autoimmune neurological diseases. As Chair, he will lead the B.C. MS Cell Therapies Translational Research Network, which is accelerating the development of next-generation therapies for people living with MS and other neurological diseases.
“I look forward to working with colleagues across the university and health system to bring the latest advances in neuroimmunology and innovative therapies closer to patients,” says Dr. Lünemann.
Learn more: https://bit.ly/430RCpX
05/27/2026
What if a simple blood test could help detect brain disorders like dementia, concussion and stroke?
A new research facility at UBC is helping make that future possible.
Led by Dr. Cheryl Wellington, the Core Facility for Neurology Biomarker Innovation (CFNBI) is advancing the development of blood biomarker tests for neurological diseases. These faster, less invasive and more accessible tools could help detect disease earlier and guide treatment decisions more precisely to improve patient outcomes.
Dr. Wellington and her team are already supporting collaborative research spanning Alzheimer’s disease, spinal cord injury, critical care medicine, pediatric brain health, wildfire smoke exposure and more.
By bringing together researchers, clinicians and partners, the CFNBI is accelerating the translation of biomarker discoveries from the lab to clinical care.
Read more: https://bit.ly/4tZ6Dne
05/21/2026
New hope for people living with severe bipolar depression https://bit.ly/3Pt0VMh
Researchers at the UBC Faculty of Medicine and collaborating institutions across Canada have shown that a new form of brain stimulation therapy could be an effective treatment for severe bipolar depression, with fewer side effects than current alternatives.
Called magnetic seizure therapy, the approach uses highly targeted magnetic pulses to stimulate the brain more precisely than existing treatments such as electroconvulsive therapy.
“Magnetic seizure therapy has the potential to become an important new tool that could help more patients access effective care,” said Dr. Fidel Vila-Rodriguez.